CN Patent

CN102971322A — 作为trk激酶抑制剂的大环化合物

Assigned to Array Biopharma Inc · Expires 2013-03-13 · 13y expired

What this patent protects

一种通式I所示的化合物及其可药用的盐，其中环A,环B,W，m,D,R 2 ,R 2a ,R 3 ,R 3a 和Z如本文所定义，其为Trk激酶的抑制剂，并且可以用于治疗疼痛、癌症、炎症、神经退行性疾病和某些传染病。

USPTO Abstract

一种通式I所示的化合物及其可药用的盐，其中环A,环B,W，m,D,R 2 ,R 2a ,R 3 ,R 3a 和Z如本文所定义，其为Trk激酶的抑制剂，并且可以用于治疗疼痛、癌症、炎症、神经退行性疾病和某些传染病。

Drugs covered by this patent

Patent Metadata

Patent number
CN102971322A
Jurisdiction
CN
Classification
—
Expires
2013-03-13
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.